MeSH term
Frequency | Condition_Probility | Child | 8 | 0.0 |
Comparative Study | 5 | 0.0 |
DNA Mutational Analysis | 18 | 0.0 |
Humans | 76 | 0.0 |
Immunohistochemistry | 3 | 0.0 |
Male | 35 | 0.0 |
Mutation/*genetics | 6 | 0.0 |
Research Support, Non-U.S. Gov't | 56 | 0.0 |
Child, Preschool | 6 | 0.0 |
Chromatography, High Pressure Liquid | 3 | 0.0 |
DNA/chemistry/genetics | 3 | 0.0 |
Exons | 8 | 0.0 |
Exostoses, Multiple Hereditary/*genetics | 31 | 83.0 |
N-Acetylglucosaminyltransferases/*genetics | 9 | 50.0 |
Polymerase Chain Reaction | 9 | 0.0 |
Proteins/genetics | 3 | 0.0 |
Animals | 25 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 28 | 0.0 |
Adult | 9 | 0.0 |
Bone Neoplasms/*genetics | 3 | 6.0 |
N-Acetylglucosaminyltransferases/genetics | 6 | 60.0 |
DNA, Neoplasm/*genetics | 2 | 0.0 |
Middle Aged | 8 | 0.0 |
RNA, Messenger/analysis | 2 | 0.0 |
Chromosomes, Human, Pair 19/genetics | 3 | 2.0 |
English Abstract | 2 | 0.0 |
*Germ-Line Mutation | 2 | 0.0 |
Linkage (Genetics) | 9 | 0.0 |
Proteins/*genetics | 21 | 1.0 |
Adolescent | 7 | 0.0 |
Age of Onset | 2 | 0.0 |
Aged | 7 | 0.0 |
Alleles | 3 | 0.0 |
Base Sequence | 19 | 0.0 |
Family Health | 3 | 0.0 |
Female | 31 | 0.0 |
Infant | 2 | 0.0 |
Loss of Heterozygosity | 5 | 0.0 |
Mutation | 9 | 0.0 |
Mutation, Missense | 3 | 0.0 |
Pedigree | 18 | 0.0 |
Polymorphism, Single-Stranded Conformational | 9 | 0.0 |
China | 2 | 0.0 |
DNA Primers | 7 | 0.0 |
*Mutation | 8 | 0.0 |
*N-Acetylglucosaminyltransferases | 28 | 71.0 |
Chromosomes, Human, Pair 11/genetics | 3 | 1.0 |
Chromosomes, Human, Pair 8/genetics | 5 | 5.0 |
Phenotype | 2 | 0.0 |
Sequence Alignment | 5 | 0.0 |
COS Cells | 7 | 0.0 |
*Membrane Proteins | 7 | 0.0 |
Molecular Sequence Data | 22 | 0.0 |
*Multigene Family | 2 | 0.0 |
N-Acetylglucosaminyltransferases/*genetics/*metabolism | 2 | 33.0 |
Recombinant Proteins/metabolism | 2 | 0.0 |
Substrate Specificity | 3 | 0.0 |
Transfection | 4 | 0.0 |
*Tumor Suppressor Proteins | 4 | 0.0 |
Blotting, Western | 2 | 0.0 |
Catalysis | 2 | 0.0 |
Genes, Tumor Suppressor/*genetics | 4 | 1.0 |
Heparitin Sulfate/*biosynthesis | 7 | 70.0 |
Protein Binding | 3 | 0.0 |
Solubility | 2 | 0.0 |
Sequence Deletion | 6 | 0.0 |
Introns | 5 | 0.0 |
Chromosomes, Human, Pair 11 | 5 | 1.0 |
Magnetic Resonance Imaging | 2 | 0.0 |
Cloning, Molecular | 10 | 0.0 |
Osteochondroma/*genetics/pathology | 2 | 100.0 |
Parathyroid Hormone-Related Protein | 2 | 2.0 |
Genes, Tumor Suppressor | 7 | 0.0 |
Cell Line | 7 | 0.0 |
Cell Differentiation/genetics | 3 | 1.0 |
Gene Expression Regulation, Developmental | 2 | 0.0 |
Mice | 14 | 0.0 |
Proteins/genetics/*physiology | 2 | 1.0 |
Reverse Transcriptase Polymerase Chain Reaction | 3 | 0.0 |
Genes, Tumor Suppressor/genetics | 3 | 1.0 |
*Trans-Activators | 2 | 0.0 |
Amino Acid Sequence | 18 | 0.0 |
Blotting, Northern | 5 | 0.0 |
Exostoses, Multiple Hereditary/*genetics/pathology | 4 | 80.0 |
Gene Expression | 3 | 0.0 |
Models, Biological | 2 | 0.0 |
Sequence Analysis, DNA | 7 | 0.0 |
*Linkage (Genetics) | 4 | 0.0 |
Microsatellite Repeats/genetics | 2 | 0.0 |
Macromolecular Substances | 2 | 0.0 |
Microscopy, Fluorescence | 2 | 0.0 |
Proteins/*genetics/physiology | 2 | 2.0 |
Bone Development/genetics | 2 | 22.0 |
DNA Primers/genetics | 2 | 0.0 |
Golgi Apparatus/*metabolism | 2 | 2.0 |
Point Mutation | 3 | 0.0 |
Chromosome Deletion | 3 | 0.0 |
Cattle | 2 | 0.0 |
Exostoses, Multiple Hereditary/genetics | 4 | 66.0 |
Glycosyltransferases/metabolism | 2 | 28.0 |
Chromosome Mapping | 12 | 0.0 |
Chromosomes, Human, Pair 8 | 5 | 3.0 |
DNA, Complementary | 3 | 0.0 |
Langer-Giedion Syndrome/*genetics | 2 | 25.0 |
Amino Acid Substitution | 2 | 0.0 |
*Chromosomes, Human, Pair 8 | 9 | 3.0 |
Langer-Giedion Syndrome/genetics | 2 | 100.0 |
Frameshift Mutation | 2 | 0.0 |
Models, Genetic | 4 | 0.0 |
Osteochondroma/*genetics | 2 | 100.0 |
Gene Deletion | 3 | 0.0 |
N-Acetylglucosaminyltransferases/genetics/*metabolism | 4 | 44.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 5 | 0.0 |
RNA, Messenger/metabolism | 2 | 0.0 |
*Chromosome Mapping | 2 | 0.0 |
Mice, Inbred C57BL | 3 | 0.0 |
Multigene Family | 3 | 0.0 |
*Genes, Tumor Suppressor | 5 | 0.0 |
Molecular Weight | 2 | 0.0 |
*Chromosomes, Human, Pair 11 | 5 | 0.0 |
Karyotyping | 2 | 0.0 |
*Chromosomes, Human, Pair 19 | 2 | 0.0 |
*Genetic Heterogeneity | 2 | 1.0 |
Proteins/chemistry/*genetics/*isolation & purification | 2 | 100.0 |
Sequence Homology, Amino Acid | 6 | 0.0 |
DNA, Complementary/genetics | 2 | 0.0 |
Hybrid Cells | 2 | 0.0 |
Chromosomes, Artificial, Yeast | 3 | 0.0 |
Genetic Markers | 6 | 0.0 |
In Situ Hybridization, Fluorescence | 6 | 0.0 |
Heterozygote | 4 | 0.0 |
Chromosomes, Human, Pair 19 | 2 | 1.0 |
Exostoses, Multiple Hereditary/complications/*genetics | 2 | 100.0 |
Signal Transduction/*physiology | 2 | 0.0 |
Gene Library | 2 | 0.0 |
Restriction Mapping | 2 | 0.0 |
*Chromosome Deletion | 2 | 0.0 |
Lod Score | 2 | 0.0 |
Chromosomes, Human, Pair 8/*genetics | 2 | 1.0 |
Fibroblast Growth Factors/metabolism | 2 | 3.0 |
